Effect of oral pentoxifylline on cystoid macular edema associated with central retinal vein occlusion

Retina

Volumn 27, Issue 8, 2007, Pages 1020-1025

  Park, Carl H ^a   Scott, Adrienne W ^b   Fekrat, Sharon ^b,c  

^a WILLS EYE HOSPITAL   (United States)

^b DUKE UNIVERSITY EYE CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Central retinal vein occlusion; Cystoid macular edema; Hemorheologic therapy; Pentoxifylline; Trental

Indexed keywords

PENTOXIFYLLINE;

ADULT; AGED; ARTICLE; BIOMICROSCOPY; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DATA COLLECTION METHOD; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; MALE; MEDICAL RECORD REVIEW; OPTICAL COHERENCE TOMOGRAPHY; RETINA MACULA CYSTOID EDEMA; STATISTICAL ANALYSIS; TREATMENT DURATION; VISUAL ACUITY;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; PENTOXIFYLLINE; PLATELET AGGREGATION INHIBITORS; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 37349096945     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3180603071     Document Type: Article

References (22)

1. Jull A, Waters J, Arroll B. Pentoxifylline for treatment of venous leg ulcers: a systemic review. Lancet 2002;359:1550-1554.
2. Reynolds H. Pentoxifylline: more evidence that it improves host defenses during sepsis. Crit Care Med 1999;27:681-683.
3. Schuppan D, Strobel D, Hahn EG. Hepatic fibrosis: therapeutic strategies. Digestion 1998;59:385-390.
4. Ward A, Clissold SP. Pentoxifylline: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 1987;34:50-97.
5. The Central Vein Occlusion Study Group. Evaluation of grid laser pattern photocoagulation for macular edema in central vein occlusion. Ophthalmology 1995;102:1425-1433.
6. The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 1997;115:486-491.
7. Fekrat S, Goldberg MF, Finkelstein D. Laser induced chorioretinal venous anastomosis for nonischemic central or branch retinal vein occlusion. Arch Ophthalmol 1998;116:43-52.
8. Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002;86:247-248.
9. Glacet-Bernard A, Kuhn D, Vine AK, Oubraham H, Coscas G, Soubrane G. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study. Br J Ophthalmol 2000;84:609-613.
10. Heyreh SS. Management of central retinal vein occlusion. Ophthalmologica 2003:167-188.
11. Hayreh SS. Correspondence: Radial optic neurotomy for central retinal vein occlusion. Retina 2002;22:374-377.
12. Peduzzi M, Debbia A, Guerrieri F, Bolzani R. Abnormal blood rheology in retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 1986;224:83-85.
13. Arend O, Remky A, Jung F, Kiesewetter H, Reim M, Wolf S. Role of rheologic factors in patients with acute central retinal vein occlusion. Ophthalmology 1996;103:80-86.
14. Glacet-Bernard A, Chabanel A, Lelong F, Samama MM, Coscas G. Elevated erythrocyte aggregation in patients with central retinal vein occlusion and without conventional risk factors. Ophthalmology 1994;101:1483-1487.
15. Peduzzi M, Codeluppi L, Poggi M, Baraldi P. Abnormal blood viscosity and erythrocyte deformability in retinal vein occlusion. Am J Ophthalmol 1983;96:399-400.
16. Wolf S, Arend O, Bertram B, et al. Hemodilution therapy in central retinal vein occlusion: one year results of a prospective randomized trial. Graefes Arch Clin Exp Ophthalmol 1994;232:33-39.
17. Luckie AP, Wroblewski JJ, Hamilton P, et al. A randomized prospective study of outpatient haemodilution for central retinal vein obstruction. Aust NZ J Ophthalmol 1996;24:223-232.
18. Glacet-Bernard A, Coscas G, Chabanel A, Zourdani A, Lelong F, Samama MM. A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin. Am J Ophthalmol 1994;118:421-429.
19. The Central Vein Occlusion Study Group. Evaluation of grid-pattern photocoagulation for macular edema in central vein occlusion: the CRVOS group M report. Ophthalmology 1995;102:1425-1433.
20. Sonkin PL, Kelly LW, Sinclair SH, Hatchell DL. Pentoxifylline increases retinal capillary blood flow velocity in patients with diabetes. Arch Ophthalmol 1993;111:1647-1652.
21. Ji Q, Zhang L, Lv R, Jia H, Xu J. Pentoxifylline decreases up-regulated nuclear factor kappa B activation and cytokine production in the rat retina following transient ischemia. Ophthalmologica 2006;220:217-224.
22. Demir T, Ulas F, Ozercan I, et al. Protective effects of pentoxifylline in retinal ischemia/reperfusion injury Ophthalmologica 2003;217:337-341.